Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: J Immunol. 2013 Dec 9;192(1):41–51. doi: 10.4049/jimmunol.1301277

Table 1.

Subcellular distribution of Munc18-2 and Syntaxin3 in RPMC and effect of nocodazol and taxol treatment.

Munc18-2 GP Syntaxin3 GP
Treatment SG surface SG matrix Filamentous Connections SG surface SG matrix Filamentous Connections
No treatment (25) 13.8 ± 0.9a 66.4 ± 5.0 19.9 ± 5.0 22.5 ± 2.7 68.1 ± 3.0 9.4 ± 2.1
Nocodazole (17) 26.9 ± 3.9b
p < 0.001
67.9 ± 3.7 3.3 ± 1.6 38.8 ± 6.4
p < 0.02
54.9 ± 5.1 4.4 ± 2.2
Taxol (16) 29.4 ± 2.5
p = 0.001
66.0 ± 4.5 4.5 ± 1.4 31.4 ± 5.1 67.8 ± 5.1 0.8 ± 0.6
p < 0.02
a

Values are the mean (± SEM) of the % of Gold Particles (GP) in each subcellular compartment taking the total number of GPs in each picture as 100 %. The numbers of pictures scored is shown in parenthesis. Total GPs scored were at least 200 and 1500 for Syntaxin3 and Munc18-2, respectively

b

Numbers in bold indicate statistical significant differences as compared to untreated cells. Statistical analysis was carried out using GraphPAD Prism5 program. P was calculated using Student's t test for unpaired data, two tailed.